نتائج البحث - Ron Epelbaum
- يعرض 1 - 17 نتائج من 17
-
1
-
2
Fertility after treatment for Hodgkin's disease حسب Zeev Blumenfeld, Eldad J. Dann, Irit Avivi, Ron Epelbaum, Jacob M. Rowe
منشور في 2002Revisão -
3
-
4
Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy حسب Zeev Blumenfeld, I. Avivi, Shai Linn, Ron Epelbaum, Menachem Ben-Shahar, Nissim Haim
منشور في 1996Artigo -
5
-
6
Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic <sup>18</sup>F-FDG PET/CT حسب Ron Epelbaum, Alex Frenkel, Riad Haddad, Natalia Sikorski, Ludwig G. Strauss, Ora Israel, Antonia Dimitrakopoulou‐Strauss
منشور في 2012Artigo -
7
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin ly... حسب Eldad J. Dann, Ron Epelbaum, Irit Avivi, Menachem Ben Shahar, Nissim Haim, Jacob M. Rowe, Zeev Blumenfeld
منشور في 2005Artigo -
8
Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG) حسب Thomas Cerny, Steven Kaplan, N. Pavlidis, Patrick Schöffski, Ron Epelbaum, J Van Meerbeek, J. Wanders, H. R. Franklin, S.B. Kaye
منشور في 1994Artigo -
9
-
10
-
11
Primary spinal epidural lymphoma: Patients’ profile, outcome, and prognostic factors: A multicenter Rare Cancer Network study حسب Virginie Monnard, A. Sun, Ron Epelbaum, Philip Poortmans, Robert C. Miller, Tom Verschueren, Luciano Scandolaro, S. Villà, Sabine Balmer Majno, Sandrine Ostermann, Mahmut Özsahin, René-Olivier Mirimanoff
منشور في 2006Artigo -
12
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome حسب Eldad J. Dann, Rachel Bar‐Shalom, Ada Tamir, Nissim Haim, Menachem Ben‐Shachar, Irit Avivi, Tzila Zuckerman, Mark Kirschbaum, Odelia Goor, Diana Libster, Jacob M. Rowe, Ron Epelbaum
منشور في 2006Artigo -
13
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> Mutation حسب Rachna T. Shroff, Andrew Hendifar, Robert R. McWilliams, Ravit Geva, Ron Epelbaum, Lindsey Rolfe, Sandra Goble, Kevin Lin, Andrew V. Biankin, Heidi Giordano, Robert H. Vonderheide, Susan M. Domchek
منشور في 2018Artigo -
14
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer حسب Talia Golan, Tal Sella, Eileen M. O’Reilly, Matthew H. G. Katz, Ron Epelbaum, David P. Kelsen, Ayelet Borgida, Hannah Maynard, Hedy L. Kindler, Eitan Friedmen, Milind Javle, Steven Gallinger
منشور في 2017Artigo -
15
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers حسب Talia Golan, Zaheer Kanji, Ron Epelbaum, Nicholas Devaud, Efrat Dagan, Spring Holter, Dan Aderka, Shani Paluch‐Shimon, Brett A. Kaufman, Ruth Gershoni‐Baruch, David W. Hedley, Malcolm J. Moore, Eitan Friedman, Steven Gallinger
منشور في 2014Artigo -
16
Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Salivary Glands: A Multicenter Rare Cancer Network Study حسب Yavuz Anacak, Robert C. Miller, Nikos Constantinou, A.M. Mamusa, Ron Epelbaum, Ye‐Xiong Li, Anna Lucas Calduch, Anna Kowalczyk, Damien C. Weber, Sidney P. Kadish, Nuran Beşe, P. Poortmans, Serra Kamer, Mahmut Özsahin
منشور في 2010Artigo -
17
Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study حسب Wendy Jeanneret‐Sozzi, Alphonse G. Taghian, Ron Epelbaum, Philip Poortmans, Daniel R. Zwahlen, Beat Amsler, S. Villette, Yazid Belkacémi, Tan Dat Nguyen, Pierre Scalliet, P. Maingon, Cristina Gutiérrez, Pauline Gastelblum, Marco Krengli, Rita Abi Raad, Mahmut Özsahin, René‐Olivier Mirimanoff
منشور في 2008Artigo
أدوات البحث:
موضوعات ذات صلة
Internal medicine
Medicine
Chemotherapy
Biology
Cancer
Oncology
Cyclophosphamide
Gastroenterology
Lymphoma
Paleontology
Pancreatic cancer
Stage (stratigraphy)
Surgery
Breast cancer
Regimen
Vincristine
BRCA mutation
Chemotherapy regimen
Endocrinology
Gene
Genetics
Hormone
Luteinizing hormone
Nuclear medicine
Ovulation
Pathology
Procarbazine
Radiation therapy
Adenocarcinoma
Biochemistry